Delivery Order SPE2DB22D3501-SPE2DB24FXD13

Award Date 9/26/24
Potential Completion Date 9/27/24
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Delivery Order with a Firm Fixed Price valued at $2,574.74, with a completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a child of a larger Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $10,479.42, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $9,092.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP77D, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,389.97, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of August 26, 2024. Amerisourcebergen Drug Corp is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a firm fixed price ceiling value of $6,622.09 and a completion date of June 14, 2024. This award appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,575.16, is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has a period of performance ending on July 10, 2024 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.78, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $6,585.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565264514 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 29, 2024. This award is not associated with a set-aside designation. The...
This federal contract award, valued at $1,244.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FXD13
    Delivery Order

This federal contract award, with a ceiling value of $23,028.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a medication, with an ultimate completion date of September 27, 2024. This is a firm fixed price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded multiple federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian agencies to provide a wide range of pharmaceutical products and medical supplies to support government healthcare programs and military treatment facilities nationwide.

Generated 12/26/24, 9:08 AM